Cambridge Antibody Technology facility.AstraZeneca

AstraZeneca's MedImmune expands biologics unit

AstraZeneca subsidiary MedImmune Inc opened a new biologics research and development centre in Cambridge, UK, a major expansion to its base at the former Cambridge Antibody Technology facility.
22 Oct 2008